Peptide mass mapping in bioapatites isolated from animal bones
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu časopisecké články
PubMed
32152749
DOI
10.1007/s10856-020-06371-z
PII: 10.1007/s10856-020-06371-z
Knihovny.cz E-zdroje
- MeSH
- apatity chemie MeSH
- biokompatibilní materiály chemie MeSH
- femur patologie MeSH
- hmotnostní spektrometrie MeSH
- keramika chemie MeSH
- kolagen typu I chemie MeSH
- kosti a kostní tkáň chemie MeSH
- organické látky chemie MeSH
- peptidy chemie MeSH
- proteomika MeSH
- skot MeSH
- teplota MeSH
- tkáňové inženýrství metody MeSH
- tlak MeSH
- velikost částic MeSH
- zvířata MeSH
- Check Tag
- skot MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- apatity MeSH
- biokompatibilní materiály MeSH
- kolagen typu I MeSH
- organické látky MeSH
- peptidy MeSH
Bioapatite ceramics produced from biogenic sources provide highly attractive materials for the preparation of artificial replacements since such materials are not only more easily accepted by living organisms, but bioapatite isolated from biowaste such as xenogeneous bones also provides a low-cost material. Nevertheless, the presence of organic compounds in the bioapatite may lead to a deterioration in its quality and may trigger an undesirable immune response. Therefore, procedures which ensure the elimination of organic compounds through bioapatite isolation are being subjected to intense investigation and the presence of remaining organic impurities is being determined through the application of various methods. Since current conclusions concerning the conditions suitable for the elimination of organic compounds remain ambiguous, we used the mass spectrometry-based proteomic approach in order to determine the presence of proteins or peptides in bioapatite samples treated under the most frequently employed conditions, i.e., the alkaline hydrothermal process and calcination at 500 °C. Since we also investigated the presence of proteins or peptides in treated bioapatite particles of differing sizes, we discovered that both calcination and the size of the bioapatite particles constitute the main factors influencing the presence of proteins or peptides in bioapatite. In fact, while intact proteins were detected even in calcinated bioapatite consisting of particles >250 µm, no proteins were detected in the same material consisting of particles <40 µm. Therefore, we recommend the use of powdered bioapatite for the preparation of artificial replacements since it is more effectively purified than apatite in the form of blocks. In addition, we observed that while alkaline hydrothermal treatment leads to the non-specific cleavage of proteins, it does not ensure the full degradation thereof.
Zobrazit více v PubMed
Nat Protoc. 2008;3(9):1444-51 PubMed
Connect Tissue Res. 1996;33(4):275-82 PubMed
Biomed Mater. 2011 Jun;6(3):035003 PubMed
Calcif Tissue Res. 1973;12(1):73-90 PubMed
J Nanosci Nanotechnol. 2014 Jan;14(1):546-63 PubMed
Rapid Commun Mass Spectrom. 2009 Dec;23(23):3843-54 PubMed
Anal Biochem. 2008 Mar 15;374(2):325-34 PubMed
Mol Cell Proteomics. 2012 Mar;11(3):M111.013987 PubMed
J Proteomics. 2010 Aug 5;73(9):1740-6 PubMed
Mol Cell Proteomics. 2005 Sep;4(9):1265-72 PubMed
Materials (Basel). 2010 Oct 15;3(10):4761-4772 PubMed
Biomaterials. 2004 Mar;25(6):987-94 PubMed
Biomaterials. 1994 May;15(6):433-7 PubMed
Rapid Commun Mass Spectrom. 2004;18(17):1896-900 PubMed
J Ultrastruct Res. 1970 Sep;32(5):545-8 PubMed
J Biomed Mater Res. 2000;53(3):227-34 PubMed
J Inorg Biochem. 1997 Oct;68(1):45-51 PubMed
Biomaterials. 2004 Jan;25(2):229-38 PubMed
Nature. 2011 May 19;473(7347):337-42 PubMed
Mol Cell Proteomics. 2006 Jan;5(1):144-56 PubMed
Nature. 2009 Aug 6;460(7256):762-5 PubMed
Biomed Mater. 2018 Apr 11;13(4):041001 PubMed
J Biol Chem. 1951 Nov;193(1):265-75 PubMed